Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand.

Tumor necrosis factor (TNF)-alpha and Fas ligand (FasL) are trimeric proteins that induce apoptosis through similar caspase-dependent pathways. Hepatocytes are particularly sensitive to inflammation-induced programmed cell death, although the contribution of TNF-alpha and/or FasL to this injury response is still unclear. Here, we report that D-galactosamine and lipopolysaccharide-induced liver injury in C57BL/6 mice is associated with increased hepatic expression of both TNF-alpha and FasL mRNA. Pretreatment of mice with a TNF-binding protein improved survival, reduced plasma aspartate aminotransferase concentrations, and attenuated the apoptotic liver injury, as determined histologically and by in situ 3' OH end labeling of fragmented nuclear DNA. In contrast, pretreatment of mice with a murine-soluble Fas fusion protein (Fasfp) had only minimal effect on survival, and apoptotic liver injury was either unaffected or exacerbated depending on the dose of Fasfp employed. Similarly, mice with a spontaneous mutation in FasL (B6Smn.C3H-Fasl(gld) derived from C57BL/6) were equally sensitive to D-galactosamine/lipopolysaccharide-induced shock. We conclude that the shock and apoptotic liver injury after D-galactosamine/lipopolysaccharide treatment are due primarily to TNF-alpha release, whereas increased FasL expression appears to contribute little to the mortality and hepatic injury.

[1]  L. Moldawer,et al.  Discordant tumor necrosis factor-alpha superfamily gene expression in bacterial peritonitis and endotoxemic shock. , 1999, Surgery.

[2]  J. Dhainaut,et al.  LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. , 1999, American journal of respiratory and critical care medicine.

[3]  B. Haynes,et al.  Resistance of CD7-deficient Mice to Lipopolysaccharide-induced Shock Syndromes , 1999, The Journal of experimental medicine.

[4]  S. Akira,et al.  IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. , 1999, International immunology.

[5]  Y. Iwakura,et al.  Involvement of Fas/Fas ligand system‐mediated apoptosis in the development of concanavalin A‐induced hepatitis , 1998, European journal of immunology.

[6]  G. Nabel,et al.  Regulation of the proinflammatory effects of Fas ligand (CD95L). , 1998, Science.

[7]  S. Nagata,et al.  Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand , 1998, Nature Medicine.

[8]  K. Iwabuchi,et al.  Chemotactic activity of soluble Fas ligand against phagocytes. , 1998, Journal of immunology.

[9]  L. Moldawer,et al.  Disparate Roles for TNF-α and Fas Ligand in Concanavalin A-Induced Hepatitis , 1998, The Journal of Immunology.

[10]  L. Moldawer,et al.  Pharmacokinetics, immunogenicity, and efficacy of dimeric TNFR binding proteins in healthy and bacteremic baboon. , 1998, Journal of applied physiology.

[11]  George Kollias,et al.  In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis , 1997, European journal of immunology.

[12]  K. Takeda,et al.  Contribution of Fas ligand to T cell-mediated hepatic injury in mice. , 1997, Gastroenterology.

[13]  Y. Iwakura,et al.  Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.

[14]  L. Moldawer,et al.  A MATRIX METALLOPROTEINASE INHIBITOR PREVENTS PROCESSING OF TUMOR NECROSIS FACTOR α (TNFα) AND ABROGATES ENDOTOXIN‐INDUCED LETHALITY , 1997 .

[15]  P. M. Davis,et al.  Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and Macrophages , 1997, The Journal of experimental medicine.

[16]  S. Nagata,et al.  Essential roles of the Fas ligand in the development of hepatitis , 1997, Nature Medicine.

[17]  M. Lambert,et al.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.

[18]  M. Raff,et al.  Programmed Cell Death in Animal Development , 1997, Cell.

[19]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[20]  J. Vauthey,et al.  Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. , 1997, Journal of immunology.

[21]  J. Mountz,et al.  Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways. , 1996, Behring Institute Mitteilungen.

[22]  M. Leist,et al.  DNA fragmentation in mouse organs during endotoxic shock. , 1996, The American journal of pathology.

[23]  T. Akaike,et al.  Concanavalin A induces perforin‐mediated but not Fas‐mediated hepatic injury , 1996, Hepatology.

[24]  P. Kiener,et al.  Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils , 1996, The Journal of experimental medicine.

[25]  A. H. Drummond,et al.  Fas ligand in human serum , 1996, Nature Medicine.

[26]  N. Koide,et al.  Apoptotic cell death in the response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model , 1996, Infection and immunity.

[27]  P. Galle,et al.  Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage , 1995, The Journal of experimental medicine.

[28]  M. Leist,et al.  Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. , 1995, Gastroenterology.

[29]  M. Leist,et al.  Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. , 1995, The American journal of pathology.

[30]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[31]  M. Leist,et al.  Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. , 1995, Journal of immunology.

[32]  M. Leist,et al.  Concanavalin A—induced T‐cell—mediated hepatic injury in mice: The role of tumor necrosis factor , 1995, Hepatology.

[33]  S. Nagata,et al.  Fas-mediated apoptosis in primary cultured mouse hepatocytes. , 1994, Experimental cell research.

[34]  H. Nagai,et al.  Mechanism for Macrophage Activation against Corynebacterium parvum—Participation of T Cells and Its Lymphokines , 1994, Microbiology and immunology.

[35]  B. Ryffel,et al.  Interferon gamma receptor deficient mice are resistant to endotoxic shock , 1994, The Journal of experimental medicine.

[36]  V. V. van Hinsbergh,et al.  Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. , 1993, The Biochemical journal.

[37]  R. Zinkernagel,et al.  Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.

[38]  C. Galanos,et al.  Mechanisms of endotoxin shock and endotoxin hypersensitivity. , 1993, Immunobiology.

[39]  D. Grobelny,et al.  Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. , 1992, Biochemistry.

[40]  L. Moldawer,et al.  Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  H. Tabuchi,et al.  Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide‐induced lethality , 1991, European journal of immunology.

[42]  C. Galanos,et al.  Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin , 1986, Infection and immunity.

[43]  L. Moldawer,et al.  Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. , 1998, Journal of immunology.

[44]  L. Moldawer,et al.  A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality. , 1997, Shock.

[45]  B. Castner,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. , 1997, Nature.

[46]  H. Yagita,et al.  [Metalloproteinase-mediated release of human fas ligand]. , 1996, Nihon rinsho. Japanese journal of clinical medicine.

[47]  M. Leist,et al.  The 55-kD Tumor Necrosis Factor Receptor and CD95 Independently Signal Murine Hepatocyte Apoptosis and Subsequent Liver Failure , 1996, Molecular medicine.

[48]  A. H. Drummond,et al.  Processing of tumour necrosis factor-alpha precursor by metalloproteinases. , 1994, Nature.

[49]  S. Nagata,et al.  Fas and Fas ligand: a death factor and its receptor. , 1994, Advances in immunology.